Android app on Google Play

Roth Capital Starts Endocyte (ECYT) at Buy

February 15, 2013 7:28 AM EST Send to a Friend
Get Alerts ECYT Hot Sheet
Price: $6.40 -8.44%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 17 | New: 23
Trade ECYT Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Endocyte (NASDAQ: ECYT) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $9.43 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment